Fetal hydrops – a review and a clinical approach to identifying the cause

References

• Heinonen S, Ryynänen M, Kirkinen P. Etiology and outcome of second trimester non‐immunologic fetal hydrops. Acta Obstet Gyn Scan. 2000;79:15–18.
   PubMed Web of Science ®Google Scholar
• Derderian CS, Jeanty C, Fleck SR, et al. The many faces of hydrops. J Pediatr Surg. 2015;50:50–54.
   PubMed Web of Science ®Google Scholar
• Fukushima K, Morokuma S, Fujita Y, et al. Short-term and long-term outcomes of 214 cases of non-immune hydrops fetalis. Early Hum Dev. 2011;87:571–575.
   PubMed Web of Science ®Google Scholar
• J. R Levick. Chapter 11: Circulation of fluid between plasma, interstitium and lymph. In: An introduction to cardiovascular Physiology, 5th Edition. London: Hodder Arnold publishing; 2010. p. 188-219.
   Google Scholar
• Randenberg A. Nonimmune hydrops fetalis part I: etiology and pathophysiology. Neonatal Netw. 2010;29(15):281–295.
   PubMedGoogle Scholar
• Levick RJ, Michel CC. Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res. 2010;87:198–210.
   PubMed Web of Science ®Google Scholar
• Hellmund A, Berg C, Geipel A, et al. Prenatal diagnosis of fetal akinesia deformation sequence (FADS): a study of 79 consecutive cases. Arch Gynecol Obstet. 2016;294:697–707.
   PubMed Web of Science ®Google Scholar
• Norton ME, Chauhan SP, Dashe JS. Society for Maternal-Fetal Medicine (SMFM) clinical guideline #7: nonimmune hydrops fetalis. Am J Obstet Gynecol. 2014;212:127–139.
   PubMed Web of Science ®Google Scholar
• Désilets V, Bie I, Audibert F. No. 363-investigation and management of non-immune fetal hydrops. J Obstetrics Gynaecol Can. 2018;40:1077–1090.
   PubMed Web of Science ®Google Scholar
• Urbaniak SJ, Greiss MA. RhD haemolytic disease of the fetus and the newborn. Blood Rev. 2000;14:44–61.
   PubMed Web of Science ®Google Scholar
• Fung K, Eason E, Crane J, et al. Prevention of RH alloimmunization this guideline has been reviewed by the maternal-fetal medicine committee and the genetics committee, with input from the Rh program of Nova Scotia, and approved by the executive and council of the society of obstetricians and gynaecologists of Canada. J Obstetrics Gynaecol Can. 2003;25:765–773.
   PubMedGoogle Scholar
• Regan F, Lees C, Jones B, et al. Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT). Bjog Int J Obstetrics Gynaecol. 2019;126:e173–e185.
   PubMed Web of Science ®Google Scholar
• Kjær M, Bertrand G, Bakchoul T, et al. Maternal HPA‐1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review. Vox Sang. 2019;114:79–94.
   PubMed Web of Science ®Google Scholar
• Kamphuis M, Paridaans N, Porcelijn L, et al. Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review. Bjog Int J Obstetrics Gynaecol. 2010;117:1335–1343.
   PubMed Web of Science ®Google Scholar
• Jain V, Clarke G, Russell L, et al. A case of alloimmune thrombocytopenia, hemorrhagic anemia-induced fetal hydrops, maternal mirror syndrome, and human chorionic gonadotropin–induced thyrotoxicosis. Am J Perinatol Rep. 2013;03:041–044.
   Google Scholar
• Fang J, Dagenais SL, Erickson RP, et al. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am J Hum Genetics. 2000;67:1382–1388.
   PubMed Web of Science ®Google Scholar
• Wylie BJ, D’Alton ME. Fetomaternal hemorrhage. Obstetrics Gynecol. 2010;115:1039–1051.
   PubMed Web of Science ®Google Scholar
• Kleihauer E, Braun H, Betke K. Demonstration von fetalem Hämoglobin in den erythrocyten eines blutausstrichs. Klin Wochenschr. 1957;35:637–638.
   PubMedGoogle Scholar
• Rubod C, Houfflin V, Belot F, et al. Successful in utero treatment of chronic and massive fetomaternal hemorrhage with fetal hydrops. Fetal Diagn Ther. 2006;21:410–413.
   PubMed Web of Science ®Google Scholar
• Enders G, Biber M. Parvovirus B19 infections in pregnancy. Behr Inst Mitt. 1990;85:74–78.
   PubMedGoogle Scholar
• Jensen I, Thorsen P, Jeune B, et al. An epidemic of parvovirus B19 in a population of 3596 pregnant women: a study of sociodemographic and medical risk factors. Bjog Int J Obstetrics Gynaecol. 2000;107:637–643.
   PubMedGoogle Scholar
• Valeur-Jensen A, Pedersen CB, Westergaard T, et al. Risk factors for parvovirus b19 infection in pregnancy. Jama. 1999;281:1099–1105.
   PubMed Web of Science ®Google Scholar
• Yageashi N, Niinuma T, Chisaka H, et al. The incidence of, and factors leading to, parvovirus B19-related hydrops fetalis following maternal infection; report of 10 cases and meta-analysis. J Infection. 1998;37:28–35.
   PubMed Web of Science ®Google Scholar
• Chisaka H, Morita E, Yaegashi N, et al. Parvovirus B19 and the pathogenesis of anaemia. Rev Med Virol. 2003;13:347–359.
   PubMed Web of Science ®Google Scholar
• de Jong E, Walther F, Kroes A, et al. Parvovirus B19 infection in pregnancy: new insights and management. Prenatal Diag. 2011;31:419–425.
   PubMed Web of Science ®Google Scholar
• Giorgio E, Oronzo M, Iozza I, et al. Parvovirus B19 during pregnancy: a review. J Prenat Med. 2010;4:63–66.
   PubMedGoogle Scholar
• Ornoy A, Ergaz Z. Parvovirus B19 infection during pregnancy and risks to the fetus. Birth Defects Res. 2017;109:311–323.
   PubMedGoogle Scholar
• Xiong Y, Tan J, Liu Y, et al. The risk of maternal parvovirus B19 infection during pregnancy on fetal loss and fetal hydrops: a systematic review and meta-analysis. J Clin Virol. 2019;114:12–20.
   PubMed Web of Science ®Google Scholar
• Barron SD, Pass RF. Infectious causes of hydrops fetalis. Semin Perinatol. 1995;19:493–501.
   PubMed Web of Science ®Google Scholar
• Sarno M, Sacramento GA, Khouri R, et al. Zika virus infection and stillbirths: a case of hydrops fetalis, hydranencephaly and fetal demise. Plos Neglect Trop D. 2016;10:e0004517.
   PubMed Web of Science ®Google Scholar
• Fuchs F, Michaux K, Rousseau C, et al. Syphilis infection: an uncommon etiology of infectious nonimmune fetal hydrops with anemia. Fetal Diagn Ther. 2016;39:74–77.
   PubMed Web of Science ®Google Scholar
• Schild R, Bald R, Plath H, et al. Intrauterine management of fetal parvovirus B19 infection. Ultrasound Obst Gyn. 1999;13:161–166.
   PubMed Web of Science ®Google Scholar
• Enders M, Weidner A, Zoellner I, et al. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenatal Diag. 2004;24:513–518.
   PubMed Web of Science ®Google Scholar
• Bamberg C, Hecher K. Update on twin-to-twin transfusion syndrome. Best Pract Res Cl Ob. 2019;58:55-65.
   Web of Science ®Google Scholar
• Kontopoulos E, Chmait RH, Quintero RA. Twin-to-twin transfusion syndrome: definition, staging, and ultrasound assessment. Twin Res Hum Genet. 2016;19:175–183.
   PubMed Web of Science ®Google Scholar
• Quintero RA, Morales WJ, Allen MH, et al. Staging of Twin-Twin Transfusion Syndrome. J Perinatol. 1999;19:7200292.
   Google Scholar
• Rossi CA, Vanderbilt D, Chmait RH. Neurodevelopmental outcomes after laser therapy for twin–twin transfusion syndrome. Obstetrics Gynecol. 2011;118:1145–1150.
   PubMed Web of Science ®Google Scholar
• Arcasoy MO, Gallagher PG. Hematologic disorders and nonimmune hydrops fetalis. Semin Perinatol. 1995;19:502–515.
   PubMed Web of Science ®Google Scholar
• Chui D, Waye J. Hydrops fetalis caused by α-Thalassemia: an emerging health care problem. Blood. 1998;91:2213–2222.
   PubMed Web of Science ®Google Scholar
• Chan V, Chan T, Liang S, et al. Hydrops fetalis due to an unusual form of Hb H disease. Blood. 1985;66:224–228.
   PubMed Web of Science ®Google Scholar
• Bernini LF, Harteveld CL. 2 α-Thalassaemia. Baillière’s Clin Haematol. 1998;11:53–90.
   PubMed Web of Science ®Google Scholar
• Clark B, Thein S. Molecular diagnosis of haemoglobin disorders. Clin Lab Haematol. 2004;26:159–176.
   PubMedGoogle Scholar
• Diamond L, Blackfan K. Hypoplastic anaemia. Am J Dis Children. 1938;56:464-467.
   Google Scholar
• Aspesi A, Betti M, Sculco M, et al. A functional assay for the clinical annotation of genetic variants of uncertain significance in Diamond–Blackfan anemia. Hum Mutat. 2018;39:1102–1111.
   PubMed Web of Science ®Google Scholar
• Sankaran VG, Ghazvinian R, Do R, et al. Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia. J Clin Invest. 2012;122:2439–2443.
   PubMed Web of Science ®Google Scholar
• Gripp KW, Curry C, Olney A, et al. Diamond–Blackfan anemia with mandibulofacial dystostosis is heterogeneous, including the novel DBA genes TSR2 and RPS28. Am J Med Genet A. 2014;164:2240–2249.
   Web of Science ®Google Scholar
• Vlachos A, Blanc L, Lipton JM. Diamond Blackfan anemia: a model for the translational approach to understanding human disease. Expert Rev Hematol. 2014;7:359–372.
   PubMed Web of Science ®Google Scholar
• Noel C. Diamond–Blackfan anemia RPL35A: a case report. J Med Case Rep. 2019;13:185.
   PubMedGoogle Scholar
• Mclennan A, Chitty L, Rissik J, et al. Prenatal diagnosis of Blackfan–Diamond syndrome: case report and review of the literature. Prenatal Diag. 1996;16:349–353.
   PubMedGoogle Scholar
• Wlodarski MW, Costa L, O’Donohue M-F, et al. Recurring mutations in RPL15 are linked to hydrops fetalis and treatment independence in Diamond-Blackfan anemia. Haematologica. 2018;103:949–958.
   Web of Science ®Google Scholar
• Tamary H, Dgany O, Proust A, et al. Clinical and molecular variability in congenital dyserythropoietic anaemia type I. Brit J Haematol. 2005;130:628–634.
   PubMed Web of Science ®Google Scholar
• Liu S, Liu Y-N, Zhen L, et al. Fetal-onset congenital dyserythropoietic anemia type 1 due to CDAN1 mutations presenting as hydrops fetalis. Pediatr Hemat Oncol. 2019;35:447–450.
   Web of Science ®Google Scholar
• Chin H-L, Lee L, Koh P. Fetal-onset congenital dyserythropoietic anemia type 1 due to a novel mutation with severe iron overload and severe cholestatic liver disease. J Pediatr Hematol Oncol. 2019;41:e51–e53.
   PubMed Web of Science ®Google Scholar
• Hasle H, Clemmensen I, Mikkelsen M. Risks of leukaemia and solid tumours in individuals with Down’s syndrome. Lancet. 2000;355:165–169.
   PubMed Web of Science ®Google Scholar
• Bhatnagar N, Nizery L, Tunstall O, et al. Transient abnormal myelopoiesis and aml in down syndrome: an update. Curr Hematol Malig R. 2016;11:333–341.
   PubMed Web of Science ®Google Scholar
• Wechsler J, Greene M, vitt MA, et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of down syndrome. Nat Genet. 2002;32:148–152.
   PubMed Web of Science ®Google Scholar
• Nikolaev SI, Santoni F, Vannier A, et al. Exome sequencing identifies putative drivers of progression of transient myeloproliferative disorder to AMKL in infants with down syndrome. Blood. 2013;122:554–561.
   PubMed Web of Science ®Google Scholar
• Tamblyn J, Norton A, Spurgeon L, et al. Prenatal therapy in transient abnormal myelopoiesis: a systematic review. Archives Dis Child - Fetal Neonatal Ed. 2016;101:67.
   PubMed Web of Science ®Google Scholar
• Watanabe K. Recent advances in the understanding of transient abnormal myelopoiesis in down syndrome. Pediatr Int. 2019;61:222–229.
   PubMed Web of Science ®Google Scholar
• Okamura T, Washio Y, Yoshimoto J, et al. Exchange transfusion and cytarabine for transient abnormal myelopoiesis in hydrops fetalis. Acta Med Okayama. 2019;73:181–188.
   PubMed Web of Science ®Google Scholar
• Gajewska-Knapik K, Impey L. Congenital lung lesions: prenatal diagnosis and intervention. Semin Pediatr Surg. 2015;24:156–159.
   PubMed Web of Science ®Google Scholar
• Witlox RS, Lopriore E, Oepkes D. Prenatal interventions for fetal lung lesions. Prenatal Diag. 2011;31:628–636.
   PubMed Web of Science ®Google Scholar
• Cavoretto P, Molina F, Poggi S, et al. Prenatal diagnosis and outcome of echogenic fetal lung lesions. Ultrasound Obst Gyn. 2008;32:769–783.
   PubMed Web of Science ®Google Scholar
• Peyce D. Lower accessory pulmonary artery with intralobar sequestration of lung: a report of seven cases. J Pathol Bacteriol. 1946;58:457–467.
   PubMedGoogle Scholar
• Sepulveda W. Perinatal Imaging in bronchopulmonary sequestration. J Ultras Med. 2009;28:89–94.
   PubMed Web of Science ®Google Scholar
• Carrilho M, Tonni G, Júnior E. Fetal cardiac tumors: prenatal diagnosis and outcomes. Rev Bras Cir Cardiov. 2015;30:VI–VII.
   PubMed Web of Science ®Google Scholar
• Isaacs H. Fetal and neonatal cardiac tumors. Pediatr Cardiol. 2004;25:252–273.
   PubMed Web of Science ®Google Scholar
• Chao A, Chao A, Wang T, et al. Outcome of antenatally diagnosed cardiac rhabdomyoma: case series and a meta‐analysis. Ultrasound Obst Gyn. 2008;31:289–295.
   PubMed Web of Science ®Google Scholar
• Yuan S-M. Fetal primary cardiac tumors during perinatal period. Pediatr Neonatol. 2017;58:205–210.
   PubMed Web of Science ®Google Scholar
• Steffensen TS, Quintero RA, Kontopoulos EV, et al. Massive pericardial effusion treated with in utero pericardioamniotic shunt in a fetus with intrapericardial teratomA. Fetal Pediatr Pathol. 2009;28:216–231.
   PubMed Web of Science ®Google Scholar
• Grebille A, Mitanchez D, Benachi A, et al. Pericardial teratoma complicated by hydrops: successful fetal therapy by thoracoamniotic shunting. Prenatal Diag. 2003;23:735–739.
   PubMed Web of Science ®Google Scholar
• Bellini C, Hennekam R, Fulcheri E, et al. Etiology of nonimmune hydrops fetalis: A systematic review. Am J Med Genet A. 2009;149A:844–851.
   PubMed Web of Science ®Google Scholar
• Johnson P, Maxwell D, Tynan M, et al. Intracardiac pressures in the human fetus. Heart. 2000;84:59.
   PubMed Web of Science ®Google Scholar
• Bravo-Valenzuela N, Rocha L, Nardozza L, et al. Fetal cardiac arrhythmias: current evidence. Ann Pediatr Cardiol. 2018;11:148.
   PubMed Web of Science ®Google Scholar
• Simpson JM, Milburn A, Yates RW, et al. Outcome of intermittent tachyarrhythmias in the fetus. Pediatr Cardiol. 1997;18:78–82.
   PubMed Web of Science ®Google Scholar
• Simpson J. Impact of fetal echocardiography. Ann Pediatr Cardiol. 2009;2:41–50.
   PubMedGoogle Scholar
• Krapp M, Kohl T, Simpson J, et al. Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart. 2003;89:913.
   PubMed Web of Science ®Google Scholar
• Ishikawa S, Yamada T, Kuwata T, et al. Fetal presentation of long qt syndrome – evaluation of prenatal risk factors: a systematic review. Fetal Diagn Ther. 2013;33:1–7.
   PubMed Web of Science ®Google Scholar
• de Jesus G, Mendoza-Pinto C, de Jesus N, et al. Understanding and managing pregnancy in patients with lupus. Autoimmune Dis. 2015;2015:943490.
   PubMed Web of Science ®Google Scholar
• Marshall DA, MacDonald KV, Heidenreich S, et al. The value of diagnostic testing for parents of children with rare genetic diseases. Genet Med. 2019 Dec;21(12):2798-2806.
   Web of Science ®Google Scholar
• Mongiovi M, Fesslova V, Fazio G, et al. Diagnosis and prognosis of fetal cardiomyopathies: a review. Curr Pharm Design. 2010;16:2929–2934.
   PubMed Web of Science ®Google Scholar
• Davey B, Szwast A, Rychik J. Diagnosis and management of heart failure in the fetus. Minerva Pediatr. 2012;64:471–492.
   PubMed Web of Science ®Google Scholar
• Sivasankaran S, Sharland GK, Simpson JM. Dilated cardiomyopathy presenting during fetal life. Cardiol Young. 2005;15:409–416.
   PubMed Web of Science ®Google Scholar
• Yaoita M, Niihori T, Mizuno S, et al. Spectrum of mutations and genotype–phenotype analysis in Noonan syndrome patients with RIT1 mutations. Hum Genet. 2016;135:209–222.
   PubMed Web of Science ®Google Scholar
• Clarke SL, Bowron A, Gonzalez IL, et al. Barth syndrome. Orphanet J Rare Dis. 2013;8:23.
   PubMed Web of Science ®Google Scholar
• Steward C, Newbury‐Ecob R, Hastings R, et al. Barth syndrome: an X‐linked cause of fetal cardiomyopathy and stillbirth. Prenatal Diag. 2010;30:970–976.
   PubMed Web of Science ®Google Scholar
• Barth P, den Bogert VC, Bolhuis P, et al. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): respiratory-chain abnormalities in cultured fibroblasts. J Inherit Metab Dis. 1996;19:157–160.
   PubMed Web of Science ®Google Scholar
• Makhamreh MM, Cottingham N, Ferreira CR, et al. Non‐immune hydrops fetalis and congenital disorders of glycosylation: a systematic literature review. J Inherit Metab Dis. 2019. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Heling KS, Tennstedt C, Göldner B, et al. Prenatal diagnosis of intrapulmonary arteriovenous malformation: sonographic and pathomorphological findings. Ultrasound Obst Gyn. 2002;19:514–517.
   PubMed Web of Science ®Google Scholar
• Godfrey ME, Tworetzky W, Morash D, et al. Cardiac findings in the fetus with cerebral arteriovenous malformation are associated with adverse outcome. Fetal Diagn Ther. 2017;41:108–114.
   PubMed Web of Science ®Google Scholar
• Marinaş M, Mindrilă I, Zorilă G, et al. A severe case of aneurysmal malformation of the vein of galen, cardiac failure and intrauterine fetal death. Curr Heal Sci J. 2018;44:76–79.
   PubMedGoogle Scholar
• Darouich S, Bellamine H, Mkaouar L, et al. Congenital large cutaneous hemangioma with arteriovenous and arterioarterial malformations: a novel association. Fetal Pediatr Pathol. 2019;38:1–6.
   PubMed Web of Science ®Google Scholar
• Swamy R, Embleton N, Hale J. Sacrococcygeal teratoma over two decades: birth prevalence, prenatal diagnosis and clinical outcomes. Prenatal Diag. 2008;28:1048–1051.
   PubMed Web of Science ®Google Scholar
• Wenstrom KD, Carr SR. Fetal Surgery. Obstetrics Gynecol. 2014;124:817–835.
   PubMed Web of Science ®Google Scholar
• Akinkuotu AC, Coleman A, Shue E, et al. Predictors of poor prognosis in prenatally diagnosed sacrococcygeal teratoma: A multiinstitutional review. J Pediatr Surg. 2015;50:771–774.
   PubMed Web of Science ®Google Scholar
• Yanai N, Shveiky D. Fetal hydrops, associated with maternal propylthiouracil exposure, reversed by intrauterine therapy. Ultrasound Obst Gyn. 2004;23:198–201.
   PubMed Web of Science ®Google Scholar
• Kazakou P, Theodora M, Kanaka-Gantenbein C, et al. Fetal hyperthyroidism associated with maternal thyroid autoantibodies: A case report. Case Rep Women’s Heal. 2018;20:e00081.
   PubMedGoogle Scholar
• King J, Lachica R, RH L, et al. Diagnosis and management of hyperthyroidism in pregnancy. Obstet Gynecol Surv. 2016;71:675–685.
   PubMed Web of Science ®Google Scholar
• de Graaf G, Buckley F, Skotko BG. Estimates of the live births, natural losses, and elective terminations with down syndrome in the United States. Am J Med Genet A. 2015;167:756–767.
   Web of Science ®Google Scholar
• Bekker MN, van den Akker NM, de Mooij YM, et al. Jugular lymphatic maldevelopment in turner syndrome and trisomy 21: different anomalies leading to nuchal edema. Reprod Sci. 2008;15:295–304.
   PubMed Web of Science ®Google Scholar
• Anuk D, Tarcan A, Alioglu B, et al. Hydrops fetalis in a neonate with down syndrome, transient myeloproliferative disorder and hepatic fibrosis. Fetal Pediatr Pathol. 2007;26:223–228.
   PubMed Web of Science ®Google Scholar
• Kroes I, Janssens S, Defoort P. Ultrasound features in trisomy 13 (Patau syndrome) and trisomy 18 (Edwards syndrome) in a consecutive series of 47 cases. Facts Views Vis Obgyn. 2014;6:245–249.
   PubMedGoogle Scholar
• Sparks TN, Thao K, Lianoglou BR, et al. Nonimmune hydrops fetalis: identifying the underlying genetic etiology. Genet Med. 2019;21:1339–1344.
   PubMed Web of Science ®Google Scholar
• Jones GE, Mansour S. An approach to familial lymphoedema. Clin Med. 2017;17:552–557.
   PubMed Web of Science ®Google Scholar
• Surerus E, Huggon I, Allan L. Turner’s syndrome in fetal life. Ultrasound Obst Gyn. 2003;22:264–267.
   PubMed Web of Science ®Google Scholar
• Brown B. The ultrasonographic features of nonimmune hydrops fetalis: a study of 30 successive patients. Can Assoc Radiol J J L’association Can Des Radiologistes. 1986;37:164–168.
   PubMed Web of Science ®Google Scholar
• Libotte F, Bizzoco D, Gabrielli I, et al. Pallister–Killian syndrome: cytogenetics and molecular investigations of mosaic tetrasomy 12p in prenatal chorionic villus and in amniocytes. Strategy of prenatal diagnosis. Taiwan J Obstetrics Gynecol. 2016;55:863–866.
   PubMed Web of Science ®Google Scholar
• Machlitt A, Tennstedt C, Körner H, et al. Prenatal diagnosis of 22q11 microdeletion in an early second-trimester fetus with conotruncal anomaly presenting with increased nuchal translucency and bilateral intracardiac echogenic foci. Ultrasound Obstetrics Gynecol. 2002;19:510–513.
   PubMed Web of Science ®Google Scholar
• Public Health England. NHS fetal anomaly screening programme. London: Public Health England Publications; 2018.
   Google Scholar
• Lo D, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350:485–487.
   PubMed Web of Science ®Google Scholar
• Hu H, Wang L, Wu J, et al. Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions/microduplications in a cohort of 8141 single pregnancies. Hum Genomics. 2019;13:14.
   PubMed Web of Science ®Google Scholar
• Connell F, Gordon K, Brice G, et al. The classification and diagnostic algorithm for primary lymphatic dysplasia: an update from 2010 to include molecular findings. Clin Genet. 2013;84:303–314.
   PubMed Web of Science ®Google Scholar
• Fotiou E, Martin-Almedina S, Simpson MA, et al. Novel mutations in PIEZO1 cause an autosomal recessive generalized lymphatic dysplasia with non-immune hydrops fetalis. Nat Commun. 2015;6:8085.
   PubMed Web of Science ®Google Scholar
• Coste B, Mathur J, Schmidt M, et al. Piezo1 and piezo2 are essential components of distinct mechanically activated cation channels. Science. 2010;330:55–60.
   PubMed Web of Science ®Google Scholar
• Martin-Almedina S, Martinez-Corral I, Holdhus R, et al. EPHB4 kinase–inactivating mutations cause autosomal dominant lymphatic-related hydrops fetalis. J Clin Invest. 2016;126:3080–3088.
   PubMed Web of Science ®Google Scholar
• Li D, Wenger TL, Seiler C, et al. Pathogenic variant in EPHB4 results in central conducting lymphatic anomaly. Hum Mol Genet. 2018;27:3233–3245.
   PubMed Web of Science ®Google Scholar
• Zhang G, Brady J, Liang W-C, et al. EphB4 forward signalling regulates lymphatic valve development. Nat Commun. 2015;6:6625.
   PubMed Web of Science ®Google Scholar
• Hennekam R, Geerdink R, Hamel B, et al. Autosomal recessive intestinal lymphangiectasia and lymphedema, with facial anomalies and mental retardation. Am J Med Genet. 1989;34:593–600.
   PubMed Web of Science ®Google Scholar
• Alders M, Hogan BM, Gjini E, et al. Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans. Nat Genet. 2009;41:1272–1274.
   PubMed Web of Science ®Google Scholar
• Hogan BM, Bos FL, Bussmann J, et al. ccbe1 is required for embryonic lymphangiogenesis and venous sprouting. Nat Genet. 2009;41:396–398.
   PubMed Web of Science ®Google Scholar
• Melber DJ, Andreasen TS, Mao R, et al. Novel mutation in CCBE 1 as a cause of recurrent hydrops fetalis from Hennekam lymphangiectasia‐lymphedema syndrome‐1. Clin Case Rep. 2018;6:2358–2363.
   PubMed Web of Science ®Google Scholar
• Connell F, Kalidas K, Ostergaard P, et al. Linkage and sequence analysis indicate that CCBE1 is mutated in recessively inherited generalised lymphatic dysplasia. Hum Genet. 2010;127:231–241.
   PubMed Web of Science ®Google Scholar
• Alders M, Al-Gazali L, Cordeiro I, et al. Hennekam syndrome can be caused by FAT4 mutations and be allelic to Van Maldergem syndrome. Hum Genet. 2014;133:1161–1167.
   PubMed Web of Science ®Google Scholar
• Brouillard P, Dupont L, Helaers R, et al. Loss of ADAMTS3 activity causes Hennekam lymphangiectasia–lymphedema syndrome 3. Hum Mol Genet. 2017;26:4095–4104.
   PubMed Web of Science ®Google Scholar
• Boone PM, Paterson S, Mohajeri K, et al. Biallelic mutation of FBXL7 suggests a novel form of Hennekam syndrome. Am J Med Genet A. 2019;182(1):189-194.
   PubMed Web of Science ®Google Scholar
• Brice G, Child A, Evans A, et al. Milroy disease and the VEGFR-3 mutation phenotype. J Med Genet. 2005;42:98.
   PubMed Web of Science ®Google Scholar
• Boudon E, Levy Y, Abossolo T, et al. Antenatal presentation of hereditary lymphedema type I. Eur J Med Genet. 2015;58:329–331.
   PubMed Web of Science ®Google Scholar
• Daniel‐Spiegel E, Ghalamkarpour A, Spiegel R, et al. Hydrops fetalis: an unusual prenatal presentation of hereditary congenital lymphedema. Prenatal Diag. 2005;25:1015–1018.
   PubMed Web of Science ®Google Scholar
• Ghalamkarpour A, Morlot S, Raas‐Rothschild A, et al. Hereditary lymphedema type I associated with VEGFR3 mutation: the first de novo case and atypical presentations. Clin Genet. 2006;70:330–335.
   PubMed Web of Science ®Google Scholar
• Brice G, Mansour S, Bell R, et al. Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24. J Med Genet. 2002;39:478.
   PubMed Web of Science ®Google Scholar
• Sargent C, Bauer J, Khalil M, et al. A five generation family with a novel mutation in FOXC2 and lymphedema worsening to hydrops in the youngest generation. Am J Med Genet A. 2014;164:2802–2807.
   Web of Science ®Google Scholar
• Ghalamkarpour A, Debauche C, Haan E, et al. Sporadic in utero generalized edema caused by mutations in the lymphangiogenic genes VEGFR3 and FOXC2. J Pediatrics. 2009;155:90–93.
   PubMed Web of Science ®Google Scholar
• Aoki Y, Niihori T, Inoue S, et al. Recent advances in RASopathies. J Hum Genet. 2016;61:33–39.
   PubMed Web of Science ®Google Scholar
• Joyce S, Gordon K, Brice G, et al. The lymphatic phenotype in Noonan and Cardiofaciocutaneous syndrome. Eur J Hum Genet. 2016;24:690–696.
   PubMed Web of Science ®Google Scholar
• Tartaglia M, Kalidas K, Shaw A, et al. PTPN11 mutations in noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genetics. 2002;70:1555–1563.
   PubMed Web of Science ®Google Scholar
• Bouchikhi I, Belhassan K, Moufid F, et al. Noonan syndrome-causing genes: molecular update and an assessment of the mutation rate. Int J Pediatr Adolesc Med. 2016;3:133–142.
   PubMedGoogle Scholar
• Staboulidou I, Pereira S, de Cruz J, et al. Prevalence and outcome of absence of ductus venosus at 11+0 to 13+6 weeks. Fetal Diagn Ther. 2011;30:35–40.
   PubMed Web of Science ®Google Scholar
• Vigneswaran TV, Homfray T, Allan LD, et al. Persistently elevated nuchal translucency and the fetal heart. J Maternal-fetal Neonatal Med. 2017;31:1–13.
   PubMed Web of Science ®Google Scholar
• de Mooij YM, van den Akker NM, Bekker MN, et al. Aberrant lymphatic development in euploid fetuses with increased nuchal translucency including Noonan syndrome. Prenatal Diag. 2011;31:159–166.
   PubMed Web of Science ®Google Scholar
• Sudrié-Arnaud B, Marguet F, Patrier S, et al. Metabolic causes of nonimmune hydrops fetalis: A next-generation sequencing panel as a first-line investigation. Clin Chim Acta. 2018;481:1–8.
   PubMed Web of Science ®Google Scholar
• Gimovsky AC, Luzi P, Berghella V. Lysosomal storage disease as an etiology of nonimmune hydrops. Am J Obstet Gynecol. 2015;212:281–290.
   PubMed Web of Science ®Google Scholar
• Vianey-Saban C, Acquaviva C, Cheillan D, et al. Antenatal manifestations of inborn errors of metabolism: biological diagnosis. J Inherit Metab Dis. 2016;39:611–624.
   PubMed Web of Science ®Google Scholar
• Sheth J, Mistri M, Shah K, et al. JIMD Reports, Volume 35. 2016;47–52.
   Google Scholar
• Braverman NE, Raymond GV, Rizzo WB, et al. Peroxisome biogenesis disorders in the Zellweger spectrum: an overview of current diagnosis, clinical manifestations, and treatment guidelines. Mol Genet Metab. 2016;117:313–321.
   PubMed Web of Science ®Google Scholar
• Dursun A, Gucer S, Ebberink M, et al. Zellweger syndrome with unusual findings: non-immune hydrops fetalis, dermal erythropoiesis and hypoplastic toe nails. J Inherit Metab Dis. 2009;32:345–348.
   Web of Science ®Google Scholar
• Bianconi SE, Cross JL, Wassif CA, et al. Pathogenesis, epidemiology, diagnosis and clinical aspects of Smith–Lemli–Opitz syndrome. Expert Opin Orphan D. 2015;3:267–280.
   PubMed Web of Science ®Google Scholar
• Maymon R, Ogle R, Chitty L. Smith–Lemli–Opitz syndrome presenting with persisting nuchal oedema and non‐immune hydrops. Prenatal Diag. 1999;19:105–107.
   PubMed Web of Science ®Google Scholar
• Putnam AR, Szakacs JG, Opitz JM, et al. Prenatal death in Smith–Lemli–Opitz/RSH syndrome. Am J Med Genet A. 2005;138A:61–65.
   Web of Science ®Google Scholar
• Smith DW, Lemli L, Opitz JM. A newly recognized syndrome of multiple congenital anomalies. J Pediatrics. 1964;64:210–217.
   PubMed Web of Science ®Google Scholar
• Warman ML, Cormier‐Daire V, Hall C, et al. Nosology and classification of genetic skeletal disorders: 2010 revision. Am J Med Genet A. 2011;155:943–968.
   Web of Science ®Google Scholar
• Milks KS, Hill LM, Hosseinzadeh K. Evaluating skeletal dysplasias on prenatal ultrasound: an emphasis on predicting lethality. Pediatr Radiol. 2017;47:134–145.
   PubMed Web of Science ®Google Scholar
• Barros C, de Rezende G, Júnior E, et al. Prediction of lethal pulmonary hypoplasia by means fetal lung volume in skeletal dysplasias: a three-dimensional ultrasound assessment. J Maternal-fetal Neonatal Med. 2015;29:1–6.
   Web of Science ®Google Scholar
• Krakow D, Lachman RS, Rimoin DL. Guidelines for the prenatal diagnosis of fetal skeletal dysplasias. Genet Med. 2009;11:127.
   PubMed Web of Science ®Google Scholar
• Parilla BV, Leeth EA, Kambich MP, et al. Antenatal detection of skeletal dysplasias. J Ultras Med. 2003;22:255–258.
   PubMed Web of Science ®Google Scholar
• Geister KA, Camper SA. Advances in skeletal dysplasia genetics. Annu Rev Genom Hum G. 2015;16:1–29.
   PubMed Web of Science ®Google Scholar
• Krakow D. Skeletal dysplasias. Clin Perinatol. 2015;42:301–319.
   PubMed Web of Science ®Google Scholar
• Chitty LS, Mason S, Barrett AN, et al. Non‐invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: next‐generation sequencing allows for a safer, more accurate, and comprehensive approach. Prenatal Diag. 2015;35:656–662.
   PubMed Web of Science ®Google Scholar
• Bellini C, Donarini G, Paladini D, et al. Etiology of non‐immune hydrops fetalis: an update. Am J Med Genet A. 2015;167:1082–1088.
   Web of Science ®Google Scholar
• Agakidis C, Agakidou E, Sarafidis K, et al. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome associated with a novel mutation of FOXP3 gene. Front Pediatrics. 2019;7:20.
   PubMed Web of Science ®Google Scholar
• Shanes E, Propst L, Ouyang DW, et al. Recurrent non-immune fetal hydrops associated with IPEX syndrome. Pediatr Dev Pathol Off J Soc Pediatr Pathol Paediatr Pathol Soc. 2019 Oct;22(5):465-471.
   Google Scholar
• Xavier-da-Silva M, Moreira-Filho CA, Suzuki E, et al. Fetal-onset IPEX: report of two families and review of literature. Clin Immunol. 2015;156:131–140.
   PubMed Web of Science ®Google Scholar
• Schrander‐Stumpel C, Spruyt L, Curfs L, et al. Kabuki syndrome: clinical data in 20 patients, literature review, and further guidelines for preventive management. Am J Med Genet A. 2005;132A:234–243.
   PubMed Web of Science ®Google Scholar
• Long A, Sinkovskaya ES, Edmondson AC, et al. Kabuki syndrome as a cause of non‐immune fetal hydrops/ascites. Am J Med Genet A. 2016;170:3333–3337.
   PubMed Web of Science ®Google Scholar
• Quinlan-Jones E, Lord J, Williams D, et al. Molecular autopsy by trio exome sequencing (ES) and postmortem examination in fetuses and neonates with prenatally identified structural anomalies. Genet Med. 2019;21:1065–1073.
   PubMed Web of Science ®Google Scholar
• Kamata S, Nose K, Ishikawa S, et al. Meconium peritonitis in utero. Pediatr Surg Int. 2000;16:377–379.
   PubMed Web of Science ®Google Scholar
• Mandakini P, Ashwin D, Manisha R, et al. Urorectal septum malformation presenting as nonimmune hydrops fetalis. Prenatal Diag. 2006;26:582–584.
   PubMed Web of Science ®Google Scholar
• Kim C, Kim S, Yang Y, et al. A case of recurrent infantile polycystic kidney associated with hydrops fetalis. Yonsei Med J. 1989;30:95–103.
   PubMedGoogle Scholar
• Rodríguez MM, Chaves F, Romaguera RL, et al. Value of autopsy in nonimmune hydrops fetalis: series of 51 stillborn fetuses. Pediatr Devel Pathol. 2002;5:365–374.
   PubMed Web of Science ®Google Scholar
• Çetinkaya M, Durmaz O, Büyükkale G, et al. Neonatal Bartter syndrome and unilateral ectopic renal cyst as new renal causes of hydrops fetalis: two case reports and review of the literature. J Maternal-fetal Neonatal Med. 2013;26:1147–1150.
   PubMed Web of Science ®Google Scholar
• Debray F-G, de Halleux V, Guidi O, et al. Neonatal liver cirrhosis without iron overload caused by gestational alloimmune liver disease. Pediatrics. 2012;129:e1076–e1079.
   PubMed Web of Science ®Google Scholar
• Gherman R, Incerpi M, Wing D, et al. Ballantyne syndrome: is placental ischemia the etiology? J Maternal-fetal Med. 1998;7:227–229.
   PubMedGoogle Scholar
• da Rocha C, Guedes R, Kieling C, et al. Neonatal liver failure and congenital cirrhosis due to gestational alloimmune liver disease: a case report and literature review. Case Rep Pediatr. 2017;2017:1–7.
   Google Scholar
• Whitington PF, Kelly S, Taylor SA, et al. Antenatal treatment with intravenous immunoglobulin to prevent gestational alloimmune liver disease: comparative effectiveness of 14-week versus 18-week initiation. Fetal Diagn Ther. 2018;43:218–225.
   PubMed Web of Science ®Google Scholar
• Kaiser I. Ballantyne and triple edema. Am J Obstet Gynecol. 1971;110:115–120.
   PubMed Web of Science ®Google Scholar
• Gedikbasi A, Oztarhan K, Gunenc Z, et al. Preeclampsia due to fetal non-immune hydrops: mirror syndrome and review of literature. Hypertens Pregnancy. 2011;30:322–330.
   PubMed Web of Science ®Google Scholar
• Navarro-Perez SF, Corona-Fernandez K, Rodriguez-Chavez JL, et al. Significant clinical manifestations in ballantyne syndrome, after a case report and literature review: recognizing preeclampsia as a differential diagnosis. Case Rep Obstetrics Gynecol. 2019;2019:1–7.
   Google Scholar
• Braun T, Brauer M, Fuchs I, et al. Mirror syndrome: a systematic review of fetal associated conditions, maternal presentation and perinatal outcome. Fetal Diagn Ther. 2010;27:191–203.
   PubMed Web of Science ®Google Scholar
• Allarakia S, Khayat HA, Karami MM, et al. Characteristics and management of mirror syndrome: a systematic review (1956–2016). J Perinat Med. 2017;45:1013–1021.
   PubMed Web of Science ®Google Scholar